Opportunity Information: Apply for REQ 613 15 000027
Apply for REQ 613 15 000027
- The Zimbabwe USAID Harare in the health sector is offering a public funding opportunity titled "Zimbabwe Assistance Program in Malaria (ZAPIM)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001 USAID Foreign Assistance for Programs Overseas.
- This funding opportunity was created on Apr 23, 2015 and posted on Apr 22, 2015.
- Applicants must submit their applications by May 6, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $20,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $20,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Zimbabwe Assistance Program in Malaria (ZAPIM) is a planned USAID/Zimbabwe health activity intended to be funded through a cooperative agreement and implemented in close partnership with Zimbabwe's National Malaria Control Program (NMCP). The main idea is not to run a parallel malaria project, but to provide comprehensive technical and programmatic support that reinforces the NMCP's existing national strategy and priorities at national, provincial, district, and community levels. ZAPIM sits under USAID/Zimbabwe's broader health agenda and is designed to help reduce illness and deaths linked to major public health burdens, including malaria, alongside HIV, tuberculosis, and maternal, newborn, and child health outcomes. In USAID terms, it directly supports the Mission's Country Development Cooperation Strategy by contributing to Intermediate Result 4.1 (improved health service delivery) and Intermediate Result 4.2 (stronger health systems).
USAID outlines five core objectives for what ZAPIM should accomplish, drawing on approaches recognized as effective by the World Health Organization (WHO) and the President's Malaria Initiative (PMI), while also encouraging applicants to propose innovative additions beyond the baseline package. First, the program is expected to improve the quality of malaria case management and strengthen prevention of malaria in pregnancy, with an emphasis on strengthening services in health facilities while also engaging relevant community-level cadres when aligned with NMCP priorities. Second, it seeks to support evidence-based national policies, strategies, and systems that prevent malaria through the distribution and sustained, correct use of long-lasting insecticide-treated nets, focusing not just on giving out nets but also on ownership and consistent usage. Third, ZAPIM will develop and implement social and behavior change communication efforts that are meant to measurably improve both prevention behaviors and treatment-seeking practices, recognizing that communication and community uptake are essential for interventions like nets, testing, and prompt treatment to work. Fourth, the activity will strengthen malaria surveillance along with monitoring and evaluation and operational research, coordinating with national programs and other partners to assess how well current malaria control tools are working in real-world conditions. Fifth, it will conduct therapeutic efficacy trials on artemisinin-based combination therapy (ACT) in collaboration with the Ministry of Health and Child Care and partners, which is a key drug-resistance monitoring function with global relevance because emerging resistance threatens malaria control gains.
Structurally, USAID anticipates making a single award for a five-year period of performance, meaning one primary implementing partner will lead the activity, though USAID explicitly encourages applicants to form partnerships with organizations that bring strong expertise in areas such as malaria epidemiology, surveillance, monitoring and evaluation, operational research, behavior change communications, and therapeutic efficacy assessment. The funding level is expected to be about $20 million total across five years, subject to availability of funds, with allocations planned through the PMI annual malaria operational plan process. The opportunity is open to unrestricted applicants (essentially any eligible entity type), and there is no cost share or matching requirement stated.
This notice itself is not the application stage. It is a draft program description released for comment, with USAID inviting feedback by May 6, 2015 (sent to amagudhu@usaid.gov with a copy to harareprocure@usaid.gov). USAID notes it may revise the program description based on comments but is not obligated to do so. The formal Request for Applications (RFA) was anticipated for release around May 13, 2015 on Grants.gov, and USAID emphasizes that this announcement does not commit the agency to issue the RFA, make an award, or pay any costs related to preparing comments. Key listing details include Funding Opportunity Number REQ 613 15 000027, expected awards of one, an estimated total funding of $20,000,000 (with an award floor of $19,000,000 and ceiling of $20,000,000), and CFDA 98.001 for USAID foreign assistance programs overseas, with contact support provided through USAID Harare.
Frequently Asked Questions (FAQs) - Zimbabwe Assistance Program in Malaria (ZAPIM)
1) What is the Zimbabwe Assistance Program in Malaria (ZAPIM)?
ZAPIM is a planned USAID/Zimbabwe health activity intended to be funded through a cooperative agreement. It is designed to provide comprehensive technical and programmatic support for malaria control in Zimbabwe in close partnership with the National Malaria Control Program (NMCP).
2) Is ZAPIM meant to replace or run alongside Zimbabwe's existing malaria program?
No. The stated intent is not to run a parallel malaria project. ZAPIM is meant to reinforce and strengthen the NMCP's existing national strategy and priorities at national, provincial, district, and community levels.
3) Who is ZAPIM expected to partner with in Zimbabwe?
ZAPIM is expected to be implemented in close partnership with Zimbabwe's National Malaria Control Program (NMCP). For specific technical areas (such as drug efficacy testing), collaboration is also described with the Ministry of Health and Child Care and other partners.
4) How does ZAPIM fit within USAID/Zimbabwe's broader health priorities?
ZAPIM sits under USAID/Zimbabwe's broader health agenda, designed to help reduce illness and deaths linked to major public health burdens, including malaria, alongside HIV, tuberculosis, and maternal, newborn, and child health outcomes.
5) What USAID strategy results does ZAPIM support?
In USAID terms, ZAPIM directly supports the Mission's Country Development Cooperation Strategy by contributing to Intermediate Result 4.1 (improved health service delivery) and Intermediate Result 4.2 (stronger health systems).
6) What are the main objectives of ZAPIM?
USAID outlines five core objectives:
- Improve the quality of malaria case management and strengthen prevention of malaria in pregnancy, with an emphasis on strengthening health facility services and engaging relevant community-level cadres when aligned with NMCP priorities.
- Support evidence-based national policies, strategies, and systems to prevent malaria through distribution and sustained, correct use of long-lasting insecticide-treated nets (LLINs), emphasizing ownership and consistent usage (not only distribution).
- Develop and implement social and behavior change communication (SBCC) efforts intended to measurably improve prevention behaviors and treatment-seeking practices.
- Strengthen malaria surveillance, monitoring and evaluation, and operational research, coordinating with national programs and partners to assess performance of malaria control tools in real-world conditions.
- Conduct therapeutic efficacy trials on artemisinin-based combination therapy (ACT) in collaboration with the Ministry of Health and Child Care and partners, supporting drug-resistance monitoring.
7) What technical approaches or standards are referenced for the program design?
The objectives are described as drawing on approaches recognized as effective by the World Health Organization (WHO) and the President's Malaria Initiative (PMI). Applicants are also encouraged to propose innovative additions beyond the baseline package.
8) What does "improving malaria case management" mean in the context of this opportunity?
Based on the description, it refers to improving the quality of malaria case management services, primarily by strengthening services in health facilities, and engaging relevant community-level cadres when that engagement is aligned with NMCP priorities. (No additional case management details are provided in the notice.)
9) What is the program's focus regarding malaria in pregnancy?
The program is expected to strengthen prevention of malaria in pregnancy, with an emphasis on improving services at health facilities and, as appropriate, engaging community-level cadres consistent with NMCP priorities.
10) How does ZAPIM address long-lasting insecticide-treated nets (LLINs)?
ZAPIM is expected to support policies, strategies, and systems related to LLIN distribution and to emphasize sustained, correct use. The notice highlights that the focus goes beyond giving out nets to include ownership and consistent usage.
11) What role does social and behavior change communication (SBCC) play in ZAPIM?
ZAPIM will develop and implement SBCC efforts intended to measurably improve prevention behaviors and treatment-seeking practices. The notice emphasizes that community uptake and communication are essential for tools like nets, testing, and prompt treatment to be effective.
12) What does ZAPIM plan to do for surveillance, monitoring and evaluation, and operational research?
ZAPIM is expected to strengthen malaria surveillance and monitoring and evaluation and to support operational research. The activity will coordinate with national programs and other partners to assess how well malaria control tools are working under real-world conditions.
13) What are therapeutic efficacy trials, and which drugs are mentioned?
The notice states that ZAPIM will conduct therapeutic efficacy trials on artemisinin-based combination therapy (ACT). This is described as a key function for monitoring drug resistance, which has global relevance because emerging resistance threatens malaria control gains.
14) What type of USAID award is anticipated for ZAPIM?
USAID anticipates funding ZAPIM through a cooperative agreement.
15) How many awards does USAID expect to make?
USAID anticipates making a single award (one primary implementing partner) for this activity.
16) What is the expected period of performance?
The anticipated period of performance is five years.
17) What is the estimated funding amount for ZAPIM?
The estimated total funding is about $20 million across five years, subject to the availability of funds.
18) Are there stated minimum and maximum award sizes?
Yes. The listing details include an award floor of $19,000,000 and a ceiling of $20,000,000.
19) How will funding allocations be planned over the life of the activity?
The notice states that allocations are planned through the PMI annual malaria operational plan process.
20) Who is eligible to apply?
The opportunity is described as open to unrestricted applicants (meaning any eligible entity type), based on the information provided in the notice.
21) Is cost share or matching funding required?
No cost share or matching requirement is stated in the notice.
22) Is this notice the actual application or solicitation?
No. This is a draft program description released for comment. It is not the application stage and does not itself constitute the formal Request for Applications (RFA).
23) What is USAID requesting from the public or stakeholders at this stage?
USAID is inviting feedback (comments) on the draft program description.
24) What is the deadline to submit comments on the draft?
USAID invited feedback by May 6, 2015.
25) Where should comments be sent?
Comments were requested to be emailed to amagudhu@usaid.gov with a copy to harareprocure@usaid.gov.
26) Can USAID change the program description after receiving comments?
Yes. USAID notes it may revise the program description based on comments, but it is not obligated to do so.
27) When was the formal Request for Applications (RFA) expected to be released?
The formal RFA was anticipated for release around May 13, 2015 on Grants.gov.
28) Does this announcement guarantee an RFA will be issued or an award will be made?
No. USAID emphasizes that the announcement does not commit the agency to issue the RFA, make an award, or pay any costs related to preparing comments.
29) What is the Funding Opportunity Number for this notice?
The Funding Opportunity Number is REQ 613 15 000027.
30) What CFDA number is associated with this opportunity?
The notice lists CFDA 98.001 (USAID foreign assistance programs overseas).
31) Where is the anticipated solicitation expected to be posted?
The RFA was anticipated to be released on Grants.gov.
32) What kinds of partnerships does USAID encourage applicants to form?
Although a single award is anticipated, USAID explicitly encourages applicants to form partnerships with organizations that bring strong expertise in areas such as malaria epidemiology, surveillance, monitoring and evaluation, operational research, behavior change communications, and therapeutic efficacy assessment.
33) What is the geographic or health system scope described for ZAPIM?
The support is described as reinforcing NMCP strategy and priorities at national, provincial, district, and community levels.
34) Is there any stated point of contact for support?
The notice indicates contact support is provided through USAID Harare.
Browse more opportunities from the same category: Health
Next opportunity: 1890 Facilities Grants Program (Renewals)
Previous opportunity: Molls Cove Stream Restoration
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for REQ 613 15 000027
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (REQ 613 15 000027) also looked into and applied for these:
| Funding Opportunity |
|---|
| Zimbabwe HIV Care and Treatment Mechanism Apply for REQ 613 15 000024 Funding Number: REQ 613 15 000024 Agency: Zimbabwe USAID Harare Category: Health Funding Amount: $35,000,000 |
| Strengthening the Diagnostic Transport Network in Liberia Apply for CDC RFA GH15 1631 Funding Number: CDC RFA GH15 1631 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Innovation for HIV Vaccine Discovery (R01) Apply for RFA AI 15 019 Funding Number: RFA AI 15 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Program Supplements for Violence Intervention to Enhance Lives (VITEL) Apply for TI 15 013 Funding Number: TI 15 013 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $70,000 |
| Environmental Health Services Support for Public Health Drinking Water Programs to Reduce Drinking Water Exposures Apply for CDC RFA EH15 1507 Funding Number: CDC RFA EH15 1507 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $134,000 |
| Community Health Projects Related to Contamination at Brownfield/Land Reuse Sites Apply for CDC RFA TS15 1502 Funding Number: CDC RFA TS15 1502 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $150,000 |
| Tobacco Regulatory Science Small Grant Program for New Investigators (R03) Apply for RFA OD 15 004 Funding Number: RFA OD 15 004 Agency: National Institutes of Health Category: Health Funding Amount: $75,000 |
| Characterization of Pro and Anti Geronic Proteins and Peptides (R01) Apply for RFA AG 16 005 Funding Number: RFA AG 16 005 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Preventing Heart Attacks and Strokes in High Need Areas Apply for CDC RFA DP15 1515 Funding Number: CDC RFA DP15 1515 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,150,000 |
| Rural Quality Improvement Technical Assistance Cooperative Agreement Apply for HRSA 15 150 Funding Number: HRSA 15 150 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Innovations for Healthy Living Improving Population Health and Eliminating Health Disparities (R43)/(R44) Apply for RFA MD 15 009 Funding Number: RFA MD 15 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technologies for Improving Population Health and Eliminating Health Disparities (R41/R42) Apply for RFA MD 15 008 Funding Number: RFA MD 15 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| PPHF 2015 REACH Racial and Ethnic Approaches to Community Health (REACH) financed in part by 2015 Prevention and Public Health Funding Apply for CDC RFA DP14 141902PPHF15 Funding Number: CDC RFA DP14 141902PPHF15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Public Health Leader Fellowship Program Apply for CDC RFA PS15 1508 Funding Number: CDC RFA PS15 1508 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Dissemination of Evidence Informed Interventions to Improve Health Outcomes along the HIV Care Continuum Implementation Technical Assistance Center Apply for HRSA 15 130 Funding Number: HRSA 15 130 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Dissemination of Evidence Informed Interventions to Improve Health Outcomes along the HIV Care Continuum Dissemination and Evaluation Center Apply for HRSA 15 030 Funding Number: HRSA 15 030 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Analyses of Human Datasets and Biospecimens to Characterize Aging related Phenotypes Relationships to Circulating Polypeptides and Proteins that Reverse or Accelerate Aging Changes (R01) Apply for RFA AG 16 012 Funding Number: RFA AG 16 012 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| T1 Translational Research Novel Interventions for Prevention and Treatment of Age related Conditions (R21) Apply for PAR 15 190 Funding Number: PAR 15 190 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Consortia for Innovative AIDS Research in Nonhuman Primates (UM1) Apply for RFA AI 15 022 Funding Number: RFA AI 15 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NeuroNEXT Infrastructure Resource Access (X01) Apply for PAR 15 195 Funding Number: PAR 15 195 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "REQ 613 15 000027", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.